METROPOLITAN LIFE INSURANCE CO/NY - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$79,291
-0.6%
2,876
+8.3%
0.00%0.0%
Q2 2023$79,809
-21.8%
2,655
-5.8%
0.00%
-20.0%
Q1 2023$102,096
-6.7%
2,818
-8.1%
0.01%0.0%
Q4 2022$109,400
+10.8%
3,067
+5.1%
0.01%0.0%
Q3 2022$98,774
+17.0%
2,9180.0%0.01%
+25.0%
Q2 2022$84,389
-10.5%
2,9180.0%0.00%
+33.3%
Q1 2022$94,310
-75.6%
2,918
-78.0%
0.00%
-40.0%
Q4 2021$386,632
+9.3%
13,2590.0%0.01%0.0%
Q3 2021$353,618
-27.4%
13,259
-16.1%
0.01%
-28.6%
Q2 2021$486,851
+22.1%
15,812
+3.8%
0.01%
+16.7%
Q1 2021$398,643
-0.4%
15,227
-4.3%
0.01%0.0%
Q4 2020$400,145
+20.7%
15,9040.0%0.01%0.0%
Q3 2020$331,439
-12.3%
15,9040.0%0.01%
-14.3%
Q2 2020$377,720
+32.0%
15,9040.0%0.01%
+16.7%
Q1 2020$286,113
-24.2%
15,9040.0%0.01%0.0%
Q4 2019$377,243
-13.7%
15,9040.0%0.01%
-14.3%
Q3 2019$437,042
-17.0%
15,9040.0%0.01%
-22.2%
Q2 2019$526,263
-5.6%
15,9040.0%0.01%
-10.0%
Q1 2019$557,276
+5.5%
15,9040.0%0.01%
-9.1%
Q4 2018$528,331
-34.0%
15,9040.0%0.01%
-21.4%
Q3 2018$800,766
-99.9%
15,9040.0%0.01%
-6.7%
Q2 2018$951,854,000
+32.2%
15,904
+1.2%
0.02%
+50.0%
Q1 2018$719,839,000
+114890.3%
15,7170.0%0.01%
+25.0%
Q4 2017$626,000
-50.0%
15,717
-49.8%
0.01%0.0%
Q3 2017$1,252,000
-13.8%
31,298
-7.1%
0.01%
-20.0%
Q2 2017$1,452,000
+37.8%
33,6860.0%0.01%
+42.9%
Q1 2017$1,054,000
+19.9%
33,686
-3.2%
0.01%
+16.7%
Q4 2016$879,000
+2.1%
34,8030.0%0.01%0.0%
Q3 2016$861,000
+21.4%
34,8030.0%0.01%
+20.0%
Q2 2016$709,000
+54.1%
34,803
+15.5%
0.01%
+25.0%
Q1 2016$460,000
+48.9%
30,133
+31.2%
0.00%
+100.0%
Q4 2015$309,000
-4.0%
22,9710.0%0.00%0.0%
Q3 2015$322,000
-24.9%
22,971
-9.1%
0.00%
-33.3%
Q2 2015$429,000
+49.5%
25,274
+6.6%
0.00%
+50.0%
Q1 2015$287,000
+45.7%
23,7200.0%0.00%
+100.0%
Q4 2014$197,000
-4.4%
23,7200.0%0.00%0.0%
Q3 2014$206,000
-20.8%
23,7200.0%0.00%
-50.0%
Q2 2014$260,00023,7200.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders